Oligoastrocytoma

Active Research Protocols

  1. 12-C-0005 – Phase I Trial of AZD7451, A Topomysin-Receptor Kinase (TRK) Inhibitor, For Adults with Recurrent Glioblastoma Multiforme (GBM)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014